Palermo, Italy

Irene Ceidda

USPTO Granted Patents = 2 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Irene Ceidda in Ocular Disease Treatment

Introduction

Irene Ceidda is an accomplished inventor based in Palermo, Italy. She has made significant contributions to the field of ocular disease treatment through her innovative formulations. With a total of two patents to her name, her work focuses on the delivery of active ingredients using advanced nanostructured systems.

Latest Patents

Irene's latest patents include formulations that incorporate silibinin and other active ingredients within lipid nanoparticle systems of the SLN and NLC type. These formulations are designed to treat neurodegenerative ocular diseases. The versatility of the calixarene compound is highlighted, as it can charge and release active ingredients that are characterized by low water solubility and low bioavailability. This innovative approach aims to enhance the effectiveness of treatments for ocular diseases.

Career Highlights

Irene Ceidda is associated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where she continues to develop her groundbreaking work. Her research focuses on creating formulations that are not only effective but also capable of overcoming the challenges posed by low solubility and bioavailability of certain active ingredients.

Collaborations

Irene collaborates with notable colleagues, including Anna Rita Blanco and Maria Luisa Bondi. Their combined expertise contributes to the advancement of research in the field of ocular treatments.

Conclusion

Irene Ceidda's innovative work in the development of nanostructured formulations represents a significant advancement in the treatment of ocular diseases. Her contributions are paving the way for more effective therapies in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…